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immobilization.	The	 risk	was	20-	fold	 increased	after	 infection	without	 concomitant	
immobilization,	73-	fold	increased	after	immobilization	without	infection,	and	141-	fold	
increased	with	the	two	combined.	The	risk	of	PE	was	apparently	higher	after	RTIs	(OR	
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1  | INTRODUCTION
Venous	 thromboembolism	 (VTE),	 which	 encompasses	 deep	 vein	
thrombosis	(DVT)	and	pulmonary	embolism	(PE),	is	a	frequent	compli-
cation	in	hospitalized	patients,1	and	40-	50%	of	all	VTEs	are	hospital-	
related.2,3	 Established	 risk	 factors	 like	 active	 cancer,	 major	 surgery,	
central	venous	catheter	and	acute	medical	conditions,	including	acute	





ship	 between	 infection	 and	VTE,	where	 for	 instance	 immobilization	
can	 act	 both	 as	 a	 confounder	 and	 as	 an	 intermediate	 in	 the	 causal	





ity	was	an	 independent	 risk	 factor	 for	pneumonia	 in	a	 retrospective	
cohort study.10	Moreover,	pneumonia	could	be	prevented	in	patients	
with	acute	stroke	by	adding	a	passive	 turning	and	mobilization	pro-














thrombus	 formation.	 In	a	 recent	 review,	Violi	 and	coworkers	under-
scored	the	need	for	more	knowledge	on	the	relation	between	pneu-
monia	and	VTE.16
In	this	study,	we	aimed	to	 investigate	the	 impact	of	acute	 infec-
tions	alone	and	in	combination	with	immobilization	on	the	risk	of	VTE.	
We	also	aimed	to	explore	the	differential	impact	of	the	most	common	
infectious	 foci,	 namely	 respiratory	 tract	 infection	 (RTI)	 and	 urinary	
tract	 infection	 (UTI),	on	the	 location	of	the	VTE	(ie	DVT	and	PE).	To	
address	 these	aims,	we	conducted	a	case-	crossover	study	with	 inci-
dent	VTE	cases	recruited	from	the	general	population.	In	this	design,	



















provided	by	 this	 hospital.	 The	 study	was	 approved	by	 the	 regional	
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Immobilization	was	 defined	 as	 the	 presence	 of	 one	 of	 the	 fol-
lowing:	bedrest	for	three	days	or	more,	ECOG	(Eastern	Cooperative	
Oncology	Group)	score	of	 four,	or	other	 immobilizing	 factors	spec-
ified	 in	 the	 patient’s	 medical	 record	 (eg,	 confinement	 to	 wheel-
chair,	 cast	 immobilization,	 etc.).	 Infection	was	 recorded	 if	 an	 acute	
infection	was	noted	by	a	physician	 in	 the	patient’s	medical	 record,	
and	 this	 definition	 included	 both	 community-	acquired	 infections	
that	 required	 hospital	 admission	 and	 hospital-	acquired	 infections.	
Respiratory	tract	infection	was	defined	as	the	presence	of	an	upper	or	
lower	respiratory	tract	infection	noted	by	a	physician	in	the	patient’s	

















Corporation,	 College	 Station,	 TX,	 USA).	 We	 performed	 a	 post-	hoc	
power	analysis	 (asymptomatic	z-	test,	1:4	matched	design)	using	 the	
incidence	of	 infection	based	on	our	data.	 If	35%	had	an	infection	in	
the	 hazard	 period,	 and	5%	had	 an	 infection	 in	 a	 control	 period,	 45	
cases	would	be	sufficient	to	reject	the	null	hypothesis	(OR	=	1)	with	











2	days	 before	 the	VTE-	diagnosis	were	 excluded,	 to	 avoid	 adjusting	
for	hospitalizations	that	were	due	to	the	VTE.	The	same	models	were	
used	 in	 analyses	 of	 immobilization;	 however,	 these	 analyses	 were	








other	 infections	 through	 conditional	 logistic	 regression	 in	 subjects	
with	VTE,	DVT,	and	PE	respectively.	For	sensitivity	purposes,	we	also	





























Control periods Hazard period
VTE diagnosis
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weight	heparin	was	prescribed	in	138	of	the	707	(19.5%)	hazard	peri-
ods,	and	in	78	of	the	2828	(2.8%)	control	periods.





















The	 frequencies	 of	 immobilization	 and	 acute	 infection	 sepa-
rately	 and	 in	 combination,	 and	 the	 corresponding	 estimated	 risks	
of	VTE	are	shown	in	Table	3.	The	estimated	risks	of	VTE	were	high	
after	acute	infection	without	concomitant	immobilization	(OR	20.3,	
95%	CI	 13.4-	30.8),	 and	 after	 immobilization	without	 concomitant	
acute	 infection	(OR	72.5,	95%	CI	35.5-	148.0).	The	combination	of	




tion	and	different	 infectious	 foci	 for	all	 subjects	with	VTE	and	 for	
subjects	with	DVT	and	PE	separately,	as	well	as	 the	ORs	 for	VTE,	













































(N = 707) n, (%)
Control periods 







Infectionb 267	(37.8) 107	(3.8) 24.2	(17.2-	34.0) 14.6	(10.1-	21.2) 10.8	(7.2-	16.0) 11.6 
(8.0-	16.7)


























VTE-	risk.	When	 investigating	 the	 impact	of	 common	 infectious	 foci	







in	 hospitalized	 patients.	 In	 a	 population-	based	 case-	control	 study,	
infection	was	 associated	with	 a	 4.2-	fold	 increased	VTE-	risk	 regard-
less	 of	 health-	care	 setting,	 and	 the	 risk	 increased	 to	 12.5-	fold	 for	
hospital-	related	 infections.5	 Further	 adjustment	 for	 some	comorbid-
ities	and	risk	 factors	 for	VTE	decreased	the	VTE-	risk	 to	3.3-	fold	 for	
Hazard period 
(N = 707) n, (%)
Control periods 

















VTE Hazard period (N = 707) n, (%) Control periods (N = 2828)b n, (%) OR (95% CI)
All	infections 267	(37.8) 107	(3.8) 24.2	(17.2-	34.0)
Respiratory	tract	infection 98	(13.9) 29	(1.0) 21.8	(13.0-	36.5)
Urinary	tract	infection 103	(14.6) 47	(1.7) 14.6	(9.4-	22.6)
Other	infections 84	(11.9) 35	(1.2) 12.5	(8.0-	19.6)
DVT Hazard period (N = 408) n, (%) Control periods (N = 1632)c n, (%) OR (95% CI)
All	infections 143	(35.0) 60	(3.7) 19.9	(13.0-	30.6)
Respiratory	tract	infection 33	(8.1) 15	(0.9) 10.7	(5.5-	20.8)
Urinary	tract	infection 62	(15.2) 24	(1.5) 16.1	(9.0-	28.8)
Other	infections 59	(14.5) 21	(1.3) 14.0	(8.1-	24.4)
PE Hazard period (N = 299) n, (%) Control periods (N = 1196)d n, (%) OR (95% CI)
All	infections 124	(41.5) 47	(3.9) 32.4	(18.2-	57.5)
Respiratory	tract	infection 65	(21.7) 14	(1.2) 48.3	(19.4-	120.0)
Urinary	tract	infection 41	(13.7) 23	(1.9) 12.6	(6.4-	24.7)
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hospital-	diagnosed	infections.	Immobilization	was	not	a	specified	vari-
able	in	the	study,	but	immobilizing	conditions	such	as	surgery,	trauma,	
and	recent	hospitalization	were	included	in	the	adjusted	model.5 In a 
study	of	patients	included	in	the	MEDENOX-	study,	originally	investi-
gating	 the	 impact	 of	 enoxaparin	 as	 thromboprophylaxis	 in	 hospital-
ized	medical	 patients,	 acute	 infection	was	 associated	with	 a	 higher	
VTE-	risk	(RR	1.47)	compared	to	patients	hospitalized	with	other	pre-	
defined	medical	conditions	such	heart	failure	and	chronic	obstructive	






























justment	model.	As	 infection	 is	 a	 common	 cause	 of	 hospitalization,	
adjusting	 for	 immobilization	by	 this	definition	might	have	 led	 to	ad-
justment	for	infection,	and	thereby	lowered	risk	estimates.











old	 model	 emphasizing	 that	 VTE	 is	 a	 multifactorial	 disease.24 The 
presence	of	one	strong	trigger,	either	infection	or	immobilization,	will	
on	top	of	other	risk	factors	(eg,	advanced	age,	obesity,	pro-	thrombotic	






port	 previous	 results	 from	 the	MEGA-	study.15	 In	 this	 case-	control	
study,	 they	 found	a	5-	fold	 increased	 risk	of	VTE	after	pneumonia,	
and	after	adjustment	 for	 immobilization	and	“healthy	 lifestyle,”	 the	






partly	 explain	 lower	 risk	 estimates	 in	 their	 study	 compared	 to	our	
results.	 In	 agreement	with	our	 findings,	Rogers	 et	al.	 found	higher	
risk	estimates	 for	 infection	preceding	PE	 than	DVT,	and	RTI	had	a	















hospital	 setting,	 followed	 by	 computerized	 tomography	 (CT)	 scan	 if	
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increased	 risk	 of	 PE,	 but	 not	 DVT,	 in	 patients	with	 severe	 asthma,	
which	further	supports	local	inflammation	as	an	important	mechanism	
for	thrombosis	in	the	lungs.28






plete	and	validated	 registry	of	VTE	events	and	 the	 study	design	
enabling	us	to	focus	on	transient	risk	factors.	The	case-	crossover	
design	is	well	suited	to	investigate	transient	risk	factors.17 In this 
design,	risk	of	selection	bias	and	possible	confounding	by	chronic	
conditions	and	anthropometric	measures	are	reduced	since	each	
subject serves as its own control. Our study has some limitations. 
First,	we	 only	 had	 access	 to	medical	 records	 from	hospital,	 and	
therefore	 less	 severe	 infections	 diagnosed	 and	 treated	 solely	 in	
general	practice	are	not	 taken	 into	account.	As	previous	studies	
have	 found	 increased	 risk	of	VTE	after	 infections	 treated	 in	 the	
community,5,6,29	 our	 results	might	 therefore	 be	 diluted.	 Second,	
even	 if	 fixed	 confounders	 are	 controlled	 for	 through	 the	 study	
design,	 other	 (unknown)	 transient	 risk	 factors	might	 have	 influ-
enced	 the	 results.	Thus,	 although	we	 adjusted	 for	 several	 other	
VTE	 triggers,	 the	 presence	 of	 residual	 confounding	 cannot	 be	
completely	 ruled	out.	Third,	we	did	not	have	 information	on	se-
verity	of	infections,	and	could	therefore	not	stratify	for	infection	
severity.	As	we	 included	 all	 infections,	 clinical	 presentation	will	











In	 conclusion,	 hospitalization	 with	 acute	 infection	 was	 a	 fre-
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